The day will focus on issues related to the management of mental health in the pregnant and postnatal population and its implications for the newborn. Part of the day will also focus on certain gynaecological conditions such as heavy menstrual bleeding disorders, early pregnancy loss and hormone replacement therapy.
You can view the full event programme here.
This event has been designed for pharmacists involved in the care of maternity and gynaecology patients. The event is suitable for pharmacists who have recently specialised in Women’s health as well as those working at advanced levels. Whilst it is aimed primarily at secondary care pharmacists, there will be aspects of the day which may be of interest also to primary care pharmacists.
The primary aims of this masterclass are to:
- Inform and better equip pharmacists involved in the care of women with mental health issues during pregnancy and the postnatal period, and the care of babies born to them whilst on psychotropic medication.
- Provide knowledge and skills to optimise the pharmaceutical care of non-pregnant women presenting with heavy menstrual bleeding.
- Provide knowledge on the medical management of miscarriage and termination of pregnancy.
- Provide knowledge and skills to optimise hormone replacement therapy in a variety of gynaecologically related conditions.
At the end of this masterclass, participants should be able to:
- Discuss the risks and benefits of antipsychotic and antidepressant use during pregnancy.
Mental Health and Pregnancy
- Describe the impact of pregnancy on mental health, including likely changes to pre-existing mental illness with ongoing pregnancy, postnatal depression and ‘baby blues’.
- Discuss the management of the most common forms of mental illness, and the risks associated with the use of psychotropic drugs during pregnancy and breastfeeding; includes awareness of changes to medication that may be required in women planning a pregnancy, during pregnancy and in the postnatal period.
- Outline and discuss the most commonly used psychotropic drugs and factors to consider when deciding on starting, changing or stopping treatment e.g. gestation of pregnancy, breastfeeding, discontinuation symptoms in women, neonatal adaptation syndrome in baby, rapid tranquillisation, use with neuromodulatory treatments (e.g. ECT); have awareness of drug monitoring requirements in the mother and the neonate.
- Describe how to counsel patients on the benefits, risk and harms of treatments for mental health problems in pregnancy and the postnatal period, including the risks of stopping or changing a treatment suddenly.
- Outline the national concerns surrounding mental health in pregnancy e.g MBRRACE-UK report 2015, Maternal Mental Health – Women’s Voices, Feb 2017; discuss what is the role of the pharmacist in all of this.
- Describe the risk to babies born to women who have taken medication for mental disorders (psychotropic medication) during pregnancy and discuss the neonatal interventions that may be required following delivery.
Heavy Menstrual Bleeding
- Describe the most common causes of heavy menstrual bleeding and discuss the pharmaceutical and surgical management options available.
- Medical Management of Miscarriage and Termination of Pregnancy
- Discuss the pharmacological interventions available for medical management of miscarriage and termination of pregnancy.
Hormone Replacement Therapy
- Describe the various scenarios where HRT may be required and discuss the pharmacological management options available for these conditions, e.g. natural menopause, premature ovarian insufficiency, surgical menopause (post-hysterectomy), endometriosis, reduced libido, etc.
Attending this event will help you advance your professional practice and could be used as evidence in your RPS Faculty and GPhC revalidation portfolios. The day will cover Core Advanced and Specialist areas of knowledge.
In addition, peer discussion opportunities will be available at this event, which can also be used towards your CPD and portfolios. Advanced booking essential.
The pharmaceutical industry has been invited to financially support this event by booking exhibition stand space. Stand sponsors have no input into the content of the event.